Regeneron : REGN

All Regeneron Articles

244 Articles

Jon C. Ogg | Apr 3, 2020 at 9:06 AM EDT

Top Analyst Upgrades and Downgrades: CBOE, Citrix, Etsy, ICE, Lululemon, Microsoft, Peloton, Regeneron, Twitter, United Rentals and More

Friday's top analyst upgrades and downgrades included CBOE, Citrix Systems, Etsy, Intercontinental Exchange, Lululemon Athletica, Microsoft, Peloton Interactive, Regeneron Pharmaceuticals,…

Chris Lange | Mar 30, 2020 at 10:54 AM EDT

Big Pharma Advances on COVID-19

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel…

Paul Ausick | Mar 30, 2020 at 10:41 AM EDT

Consumer Confidence Declines Taper Off as FDA OKs Emergency Drugs

U.S. consumer confidence continues to decline, but the slide has slowed. On Sunday, the FDA and the Department of Health…

Chris Lange | Mar 24, 2020 at 10:11 AM EDT

How Coronavirus Stocks Are Holding Up

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal…

Chris Lange | Mar 20, 2020 at 11:34 AM EDT

Will Coronavirus Stocks End the Week With a Bang or a Whimper?

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal…

Chris Lange | Mar 18, 2020 at 10:45 AM EDT

These Are the Top Coronavirus Cure and Vaccine Companies Trying to Save Us

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel…

Jon C. Ogg | Mar 12, 2020 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Akamai, AB InBev, Boeing, BP, Comcast, Disney, Duke, Gap, Kinder Morgan, Lyft, Occidental, Snap, Tesla and More

Thursday's top analyst upgrades, downgrades and initiations included Akamai Technologies, Anheuser-Busch InBev, Boeing, BP, Comcast, Duke Energy, Gap, Kinder Morgan,…

Chris Lange | Mar 11, 2020 at 11:06 AM EDT

Coronavirus Stocks See Rising Tide in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 7, 2020 at 8:54 AM EST

10 Very Strong Stocks Thriving in a Very Crummy Stock Market

These 10 stocks have incredibly strong stock charts and strong performance despite the crummy market conditions that have been seen…

Jon C. Ogg | Feb 26, 2020 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Casper, CME, Deere, Disney, Domino’s, Home Depot, Nike, RealReal, Salesforce, SolarEdge, Sunrun and More

Wednesday's top analyst upgrades, downgrades and initiations included Casper Sleep, CME, Deere, Domino's Pizza, Home Depot, Nike, RealReal, Salesforce.com, SolarEdge…

Jon C. Ogg | Feb 25, 2020 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Aurora Cannabis, Biogen, Micron, Nio, Nvidia, Palo Alto, Tandem Diabetes, Tesla and More

Tuesday's top analyst upgrades, downgrades and initiations included Aurora Cannabis, Biogen, EverQuote, Micron Technology, Nio, Nvidia, Palo Alto Networks, Tandem…

Chris Lange | Jan 23, 2020 at 1:35 PM EST

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.

Jon C. Ogg | Dec 24, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

Christmas Eve's top analyst upgrades, downgrades and initiations included Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron Pharmaceuticals…

Jon C. Ogg | Dec 8, 2019 at 10:40 AM EST

10 Large-Cap Stocks Up 1000% to 4000% Over the Past Decade

24/7 Wall St. has identified 10 stocks that have risen 1,000% or more since the last trading day of 2009.

Jon C. Ogg | Nov 12, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva…

1 … 4 5 6 7 8 … 17

Regeneron : REGN

All Regeneron Articles

Top Analyst Upgrades and Downgrades: CBOE, Citrix, Etsy, ICE, Lululemon, Microsoft, Peloton, Regeneron, Twitter, United Rentals and More

Big Pharma Advances on COVID-19

Consumer Confidence Declines Taper Off as FDA OKs Emergency Drugs

How Coronavirus Stocks Are Holding Up

Will Coronavirus Stocks End the Week With a Bang or a Whimper?

These Are the Top Coronavirus Cure and Vaccine Companies Trying to Save Us

Top Analyst Upgrades and Downgrades: Akamai, AB InBev, Boeing, BP, Comcast, Disney, Duke, Gap, Kinder Morgan, Lyft, Occidental, Snap, Tesla and More

Coronavirus Stocks See Rising Tide in Short Interest

10 Very Strong Stocks Thriving in a Very Crummy Stock Market

Top Analyst Upgrades and Downgrades: Casper, CME, Deere, Disney, Domino’s, Home Depot, Nike, RealReal, Salesforce, SolarEdge, Sunrun and More

Top Analyst Upgrades and Downgrades: Aurora Cannabis, Biogen, Micron, Nio, Nvidia, Palo Alto, Tandem Diabetes, Tesla and More

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

10 Large-Cap Stocks Up 1000% to 4000% Over the Past Decade

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Regeneron : REGN

All Regeneron Articles

Top Analyst Upgrades and Downgrades: CBOE, Citrix, Etsy, ICE, Lululemon, Microsoft, Peloton, Regeneron, Twitter, United Rentals and More

Big Pharma Advances on COVID-19

Consumer Confidence Declines Taper Off as FDA OKs Emergency Drugs

How Coronavirus Stocks Are Holding Up

Will Coronavirus Stocks End the Week With a Bang or a Whimper?

These Are the Top Coronavirus Cure and Vaccine Companies Trying to Save Us

Top Analyst Upgrades and Downgrades: Akamai, AB InBev, Boeing, BP, Comcast, Disney, Duke, Gap, Kinder Morgan, Lyft, Occidental, Snap, Tesla and More

Coronavirus Stocks See Rising Tide in Short Interest

10 Very Strong Stocks Thriving in a Very Crummy Stock Market

Top Analyst Upgrades and Downgrades: Casper, CME, Deere, Disney, Domino’s, Home Depot, Nike, RealReal, Salesforce, SolarEdge, Sunrun and More

Top Analyst Upgrades and Downgrades: Aurora Cannabis, Biogen, Micron, Nio, Nvidia, Palo Alto, Tandem Diabetes, Tesla and More

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

10 Large-Cap Stocks Up 1000% to 4000% Over the Past Decade

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s